Edoc Acquisition announces termination of deal with Calidi Biotherapeutics

Aug. 15, 2022 2:17 AM ETEdoc Acquisition Corp. (ADOC), ADOCR, ADOCWBy: Meghavi Singh, SA News Editor
  • SPC Edoc Acquisition (NASDAQ:ADOC) announced the termination of its previously announced agreement and plan of merger with Calidi Biotherapeutics.
  • In future both parties may continue to discuss the possibility of engaging in a business combination, there can be no assurance that those discussions will result in a transaction between Edoc and Calidi proceeding on the current terms of the Business Combination, if at all.
  • As a result of the termination of the merger pact, Edoc intends to promptly begin simultaneously evaluating other possible business combination targets.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.